NCT03199430View on ClinicalTrials.gov

Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism.

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

February 29, 2016

Conditions
EGCG Influence on Catecholamine Metabolism
Interventions
DIETARY_SUPPLEMENT

Epigallocatechin gallate

DIETARY_SUPPLEMENT

Placebo

1450mg Corn Flour

All Listed Sponsors
lead

Swansea University

OTHER

NCT03199430 - Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism. | Biotech Hunter | Biotech Hunter